{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:33:10Z","timestamp":1774690390729,"version":"3.50.1"},"reference-count":46,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:00:00Z","timestamp":1146096000000},"content-version":"vor","delay-in-days":3283,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[1997,5]]},"abstract":"<jats:p>p2l<jats:sup>WAFI\/CIPI<\/jats:sup> (p21) is an inhibitor of cyclin\u2010dependent kinases recently identified as the downstream effector of wild\u2010type p53\u2010me\u2010diated cell cycle arrest. The gene coding for p21 may function as a negative regulator of melanoma growth, progression, and metastasis. Using immunohistochemistry and Western blotting, we investigated the expression of p21 in human melanocytic proliferations. Immunohistochemical staining was performed on 13 common acquired nevi, 12 dysplastic nevi, 23 primary malignant melanomas, and 12 metastatic melanomas. Common acquired nevi showed minimal p21 staining (1.8\u00b10.3%, mean\u00b1SEM). The percentage of positive nuclei was slightly elevated in dysplastic nevi (8.9\u00b11.7%). Both primary malignant melanoma (29\u00b13%) and metastatic melanoma (33\u00b15%) demonstrated a significantly increased number of p21\u2010positive nuclei compared to benign lesions (p&lt;0.001). p21 was strongly expressed even in actively proliferating lesions as confirmed by MIB\u20101 labelling, and although the majority of p21\u2010positive cells likely represent a non\u2010proliferating population, staining was occasionally observed in cells undergoing mitosis, suggesting abnormal function of this cell cycle inhibitor in malignant melanoma. Overexpression of p21 in metastatic melanoma compared to common acquired nevi was confirmed by Western blot analysis of human tumor samples. These findings suggest that increased p21 expression relative to benign nevi is not sufficient to control melanoma growth <jats:italic>in vivo.<\/jats:italic><\/jats:p>","DOI":"10.1111\/j.1600-0560.1997.tb00790.x","type":"journal-article","created":{"date-parts":[[2006,4,29]],"date-time":"2006-04-29T04:01:21Z","timestamp":1146283281000},"page":"265-271","source":"Crossref","is-referenced-by-count":47,"title":["Overexpression of the cyclin\u2010dependent kinase inhibitor p21<sup>WAF1\/GIP1<\/sup> in human cutaneous malignant melanoma"],"prefix":"10.1111","volume":"24","author":[{"given":"Martin J.","family":"Trotter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liren","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor A.","family":"Tron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7997877"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-9525(00)89027-7"},{"key":"e_1_2_1_4_2","first-page":"211","article-title":"Cell cycle control in mammalian cells: role of cyclins, cyclin\u2010dependent kinases (CDKs), growth suppressor genes and cyclin\u2010dependent kinase inhibitors (CKIs)","volume":"11","author":"Grana X","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90528-X"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90499-G"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/366701a0"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/366707a0"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90500-P"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1994.1063"},{"key":"e_1_2_1_11_2","first-page":"1855","article-title":"The melanoma differentiation\u2010associated gene mda\u20106, which encodes the cyclin\u2010dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells","volume":"10","author":"Jiang H","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.11.3781.bloodjournal84113781"},{"key":"e_1_2_1_13_2","first-page":"599","article-title":"Polymorphisms and probable lack of mutation in the WAF1\u2010CIP1 gene in colorectal cancer","volume":"10","author":"Li Y\u2010P","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199508000-00006"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-78771-3_10"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1995.tb00284.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7863329"},{"key":"e_1_2_1_18_2","first-page":"3391","article-title":"Induction of WAF1\/CIP1 by a p53\u2010inclepenclent pathway","volume":"54","author":"Michieli P","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_19_2","first-page":"3397","article-title":"Induction of differentiation in human promyelocytic HL\u201060 leukemia cells activates p21, WAF1\/CIP1, expression in the absence of p53","volume":"9","author":"Jiang H","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.12.5451"},{"key":"e_1_2_1_21_2","first-page":"3389","article-title":"Induction of p21 (WAF\u20101\/CIP1) during differentiation","volume":"9","author":"Steinman RA","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_1_22_2","first-page":"2404","article-title":"Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1\/WAF1","volume":"55","author":"Bond JA","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_1_23_2","first-page":"835","article-title":"Increase in expression level of p21sdi1\/cip1\/waf1 with increasing division age in both normal and SV40\u2010translbrmed human fibroblasts","volume":"10","author":"Tahara H","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_1_24_2","first-page":"3407","article-title":"Mechanisms of regulation of WAF1\/Cip1 gene expression in human breast carcinoma: role of p53\u2010dependent and independent signal transduction pathways","volume":"9","author":"Sheikh MS","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12321071"},{"key":"e_1_2_1_26_2","first-page":"1955","article-title":"UV\u2010B\/A irradiation of mouse keratinocytes results in p53\u2010mediated WAF1\/CIP1 expression","volume":"10","author":"Li M","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.12.5545"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1095-1052"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(90)90075-G"},{"key":"e_1_2_1_30_2","first-page":"2910","article-title":"Topological control of p21WAF1\/CIP1 expression in normal and neoplastic tissues","volume":"55","author":"El\u2010Deiry WS","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711680404"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198512053132305"},{"key":"e_1_2_1_33_2","first-page":"4536","article-title":"Tumor suppression by p21WAFI","volume":"55","author":"Chen YQ","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.4.9.897"},{"key":"e_1_2_1_35_2","first-page":"2261","article-title":"Cell cycle expression and p53 regulation of the cyclin\u2010dependent kinase inhibitor p21","volume":"9","author":"Li Y","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_1_36_2","first-page":"1069","article-title":"Becker D Differential expression of the cyclin\u2010dependent kinase inhibitors p16 and p21 in die human melanocytic system","volume":"12","author":"Wang Y","year":"1996","journal-title":"Oncogene"},{"key":"e_1_2_1_37_2","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel P","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_1_38_2","first-page":"3021","article-title":"A single nucleotide substitution at codon 31 (Ser\/Arg) defines a polymorphism in a highly conserved region of the p53\u2010inducible gene WAF1\/CIP1","volume":"9","author":"Chedid M","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7652577"},{"key":"e_1_2_1_40_2","first-page":"2713","article-title":"Loss of expression of the p16\/cyclin\u2010dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression","volume":"55","author":"Reed JA","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_1_41_2","first-page":"1409","article-title":"Abrogation of p53\u2010induced cell cycle arrest by c\u2010Myc: evidence for an inhibitor of p21WAF1\/CIP1\/SDI1","volume":"11","author":"Hermeking H","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_1_42_2","first-page":"4257","article-title":"p53, through p21 (WAF1\/CIP1), induces cyclin Dl synthesis","volume":"55","author":"Chen X","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.8.15.1750"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb06921.x"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7624789"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90396-4"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7624798"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0560.1997.tb00790.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0560.1997.tb00790.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:47:01Z","timestamp":1698403621000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0560.1997.tb00790.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["10.1111\/j.1600-0560.1997.tb00790.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0560.1997.tb00790.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}